Doxorubicin hydrochloride
Doxorubicin Hydrochloride (Liposomal) is a prescription chemotherapy drug used to treat certain cancers. It's administered intravenously as an injectable solution in strengths like 20mg/10ml or 50mg/25ml, encapsulated in liposomes to reduce side effects. Manufactured by Zydus Lifesciences Limited under ANDA212299. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Doxorubicin Hydrochloride (Liposomal) is a prescription chemotherapy drug used to treat certain cancers. It's administered intravenously as an injectable solution in strengths like 20mg/10ml or 50mg/25ml, encapsulated in liposomes to reduce side effects. Manufactured by Zydus Lifesciences Limited under ANDA212299. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Doxorubicin hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Doxorubicin hydrochloride — ANDA 091418 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091418"
}
]
|
| identifier | ANDA091418 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"drug-safety",
"health-care"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Doxorubicin hydrochloride |
